Étude ICARE 2-GETAID 2022-02 Safety of new medications in inflammatory bowel diseases: A French prospective nationwide study. ICARE II study Investigateurs Pr Laurent PEYRIN-BIROULET La fiche complète est accessible aux membres du GETAID.Se connecter